High flow nasal cannula useful for severe SARSs-CoV-2 pneumonia

Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, 8, 475, 10.1016/S2213-2600(20)30079-5

Castaneda, 2020, Impact of ventilator model on mortality: a retrospective cross-sectional study in 147 mechanically ventilated patients with Covid-19 ARDS, Chest, 158, A617, 10.1016/j.chest.2020.08.581

Xie, 2020, Association between hypoxemia and mortality in patients with COVID-19, Mayo Clin Proc, 95, 1138, 10.1016/j.mayocp.2020.04.006

Contributors, 2020, Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure, Intensive Care Med, 46, 1924, 10.1007/s00134-020-06177-1

Roca, 2010, High-flow oxygen therapy in acute respiratory failure, Respir Care, 55, 408

Calligaro, 2020, The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: a multi-center prospective observational study, EClinicalMedicine, 28, 100570, 10.1016/j.eclinm.2020.100570

Rochwerg, 2019, High-flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: author's reply, Intensive Care Med, 45, 1171, 10.1007/s00134-019-05658-2

Massachusetts General Hospital, 2020, Massachusetts General Hospital (MGH) COVID-19 treatment guidance, The General Hospital Corporation Massachusetts General Hospital, 1, 1